by James Spencer | Sep 30, 2025 | Heathcare, News
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. et al., No. 2:24-cv-00484 (E.D. Va.). In this case, Lowey Dannenberg represents CareFirst...
by James Spencer | Sep 22, 2025 | Heathcare, News
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. Plaintiff allege that drug manufacturers Takeda and...
by James Spencer | Jul 7, 2025 | Antitrust, Heathcare, News
Lowey Dannenberg, P.C. is pleased to welcome its newest partner, Joseph Nielsen, to the firm. Joe built a storied career in private and public roles representing victims of antitrust conspiracies in the technology and pharmaceutical industries. During his 19 years at...
by James Spencer | Jun 11, 2025 | Heathcare, Homepage, News
Lowey Dannenberg, P.C., is thrilled to welcome our newest partner, Matthew A. Cartwright. Matt has long distinguished himself as a trial lawyer and a public servant, and now brings his skills to Lowey. He joins Lowey’s Healthcare Litigation Team and will be based in...
by Christian Levis | Chair of Data Privacy | May 18, 2021 | Heathcare, Homepage, News
On May 14, 2021, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts granted the End-Payor Plaintiffs’ (“EPPs’”) class certification motion. The EPPs are third party payors paying some or all of the purchase price for prescription...
